Los virus de las hepatitis C y B son una de las causas de este tipo de cáncer, uno de los más frecuentes en la sangre, y de las patologías que lo preceden, las gammapatías monoclonales
Read moreThe study results demonstrate that modulating the levels of MCJ in the heart can preserve cardiac function despite the presence of lung injury.
Read moreOncoheroes Biosciences is now at a crucial moment in its quest to find effective therapies for pediatric cancer patients, as they have the unprecedented opportunity to test Volasertib, one of its thre...
Read moreThe most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant ...
Read moreEl trabajo demuestra que los ácidos grasos de cadena corta y la microbiota intestinal asociada con su producción “podrían tener efectos beneficiosos en la evolución de la enfermedad y la respues...
Read moreResearchers from IRB Barcelona describe a mechanism by which senescent cells generated by chemotherapy survive inside tumours.
Read moreResearch team has described that the ZEB1 and ZEB2 proteins oppositely regulate muscle adaptation to energy needs during fasting.
Read moreThe idea of the project is to obtain cells with the patient mutations, develop organoids, explore the possibility of gene editing processes for different mutations and create a platform for drug testi...
Read moreCRAG researchers have found how an important plant pathogen, Ralstonia solanacearum, activates certain types of genes to be able to survive in the harsh soil conditions.
Read moreHan permitido desarrollar una estrategia totalmente nueva para fabricar dosis terapéuticas de células Treg a partir de un tejido que cubre el corazón y que se desecha habitualmente en el transcurso...
Read moreEl objetivo del ensayo clínico SIMPLIFY era comprobar en estos pacientes, tratados inicialmente con un antibiótico de amplio espectro (activo frente a muchas bacterias, incluyendo bacterias multirre...
Read moreOn January 25-26, 2024, in Berlin, Germany, the JOIN4ATMP project held its Kick-off meeting, an initiative created to map, join and drive European activities for Advanced Therapy Medicinal Product (AT...
Read more